What does XBiotech Inc. do?
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions,…
What is XBiotech Inc.'s P/E and P/B ratio?
XBiotech Inc. has a P/E ratio of -1.3 and a P/B ratio of 0.47.
What is XBiotech Inc.'s debt-to-equity ratio?
XBiotech Inc. has a debt-to-equity ratio of 0.00.
How much does XBiotech Inc. owe compared with what it owns?
XBiotech Inc. owes $0.04 for every $1 it owns (balance sheet Jun 2026), which is low.
What is XBiotech Inc.'s Positivity rank?
XBiotech Inc. is ranked #1,715 of 6,774 companies globally and #419 of 4,000 in United States on PositoAI, with a Positivity Score of 22,376.
Does XBiotech Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for XBiotech Inc..
Where can I read the latest news about XBiotech Inc.?
Recent headlines about XBiotech Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does XBiotech Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of XBiotech Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.